Pasireotide
Also known as: SOM 230, SOM-230, SOM230, Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl], cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L-phenylalanyl-)
Pasireotide (CAS 396091-73-9) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C58H66N10O9 and a molecular weight of 1047.206 g/mol. Key properties include a boiling point of 1351.4±65.0 °C at 760 mmHg, a density of 1.4±0.1 g/cm3 and a flash point of 771.1±34.3 °C. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 396091-73-9
- Jingsj CID
- J-1955731-1
- Molecular Formula
- C58H66N10O9
- Molecular Weight
- 1047.206 g/mol
- Category
- Pharma Intermediates
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quotePhysicochemical Properties
| Boiling Point | 1351.4±65.0 °C at 760 mmHg |
|---|---|
| Density | 1.4±0.1 g/cm3 |
| Flash Point | 771.1±34.3 °C |
| Exact Mass | 1046.501465 |
| PSA | 281.20000 |
| LogP | 2.79 |
| Vapor Pressure | 0.0±0.3 mmHg at 25°C |
| Refractive Index | 1.680 |
| Storage Conditions | 2-8℃ |
Activity & Biological Data
| Additional Information | [1]. Lewis I, et al. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J Med Chem. 2003 Jun 5;46(12):2334-44. [2]. Hofland LJ, et al. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85. [3]. Murray RD, et al. The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion. J Clin Endocrinol Metab. 2004 Jun;89(6):3027-32. [4]. Quinn TJ, et al. Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. Surgery. 2012 Dec;152(6):1068-77. [5]. Imhof AK, et al. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis Rheum. 2011 Aug;63(8):2352-62. |
|---|
Frequently Asked Questions
What is the CAS number of Pasireotide?
The CAS number of Pasireotide is 396091-73-9.
What are the molecular formula and molecular weight of Pasireotide?
Pasireotide has molecular formula C58H66N10O9 and molecular weight 1047.206 g/mol.
Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "Pasireotide (CAS 396091-73-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1955731-1 (accessed 2026-11-07).
Data for reference only; verify product details with suppliers before purchase.